| Treatment of high-risk Philadelphia chromosome–negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual … JM Ribera, A Oriol, M Morgades, P Montesinos, J Sarrà, ... Journal of Clinical Oncology 32 (15), 1595-1604, 2014 | 293 | 2014 |
| First clinical study of the B-cell maturation antigen (BCMA) 2+ 1 T cell engager (TCE) CC-93269 in patients (Pts) with relapsed/refractory multiple myeloma (RRMM): interim … LJ Costa, SW Wong, A Bermúdez, J de la Rubia, MV Mateos, EM Ocio, ... Blood 134, 143, 2019 | 151 | 2019 |
| Post-transplantation cyclophosphamide-based haploidentical transplantation as alternative to matched sibling or unrelated donor transplantation for Hodgkin lymphoma: a registry … C Martínez, J Gayoso, C Canals, H Finel, K Peggs, A Dominietto, ... Journal of Clinical Oncology 35 (30), 3425-3432, 2017 | 149 | 2017 |
| Fatal visceral varicella-zoster infection following rituximab and chemotherapy treatment in a patient with follicular lymphoma A Bermúdez, F Marco, E Conde, E Mazo, M Recio, A Zubizarreta Haematologica 85 (8), 894-895, 2000 | 106 | 2000 |
| Comparison of aceclofenac with piroxicam in the treatment of osteoarthritis MP Busquier, E Calero, M Rodriguez, PC Arce, A Bermudez, LF Linares, ... Clinical rheumatology 16, 154-159, 1997 | 95 | 1997 |
| MYC in chronic myeloid leukemia: induction of aberrant DNA synthesis and association with poor response to imatinib M Albajar, MT Gómez-Casares, J Llorca, I Mauleon, JP Vaqué, JC Acosta, ... Molecular Cancer Research 9 (5), 564-576, 2011 | 76 | 2011 |
| Primary and secondary immunodeficiency diseases in oncohaematology: warning signs, diagnosis, and management S Sánchez-Ramón, A Bermúdez, LI González-Granado, ... Frontiers in immunology 10, 586, 2019 | 74 | 2019 |
| Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome–negative adult lymphoblastic leukemia JM Ribera, M Morgades, J Ciudad, P Montesinos, J Esteve, E Genescà, ... Blood, The Journal of the American Society of Hematology 137 (14), 1879-1894, 2021 | 61 | 2021 |
| Outcome of second allogeneic hematopoietic cell transplantation after relapse of myeloid malignancies following allogeneic hematopoietic cell transplantation: a retrospective … G Orti, J Sanz, A Bermudez, D Caballero, C Martinez, J Sierra, JRC Marin, ... Biology of Blood and Marrow Transplantation 22 (3), 584-588, 2016 | 55 | 2016 |
| Comparing iv BU dose intensity between two regimens (FB2 vs FB4) for allogeneic HCT for AML in CR1: a report from the Acute Leukemia Working Party of EBMT MA Kharfan-Dabaja, M Labopin, A Bazarbachi, RM Hamladji, D Blaise, ... Bone marrow transplantation 49 (9), 1170-1175, 2014 | 45 | 2014 |
| Unique clinico-biological, genetic and prognostic features of adult early T-cell precursor acute lymphoblastic leukemia E Genescà, M Morgades, P Montesinos, P Barba, C Gil, R Guardia, ... Haematologica 105 (6), e294, 2020 | 39 | 2020 |
| Cerebral scedosporiosis: an emerging fungal infection in severe neutropenic patients: CT features and CT pathologic correlation E Marco de Lucas, P Sádaba, P Lastra García-Barón, ML Ruiz Delgado, ... European radiology 16, 496-502, 2006 | 39 | 2006 |
| Alnuctamab (ALNUC; BMS-986349; CC-93269), a B-cell maturation antigen (BCMA) x CD3 T-cell engager (TCE), in patients (pts) with relapsed/refractory multiple myeloma (RRMM … SW Wong, N Bar, L Paris, CC Hofmeister, M Hansson, A Santoro, ... Blood 140 (Supplement 1), 400-402, 2022 | 36 | 2022 |
| Unrelated transplantation for poor-prognosis adult acute lymphoblastic leukemia: long-term outcome analysis and study of the impact of hematopoietic graft source C Ferrá, J Sanz, R de la Cámara, G Sanz, A Bermúdez, D Valcárcel, ... Biology of Blood and Marrow Transplantation 16 (7), 957-966, 2010 | 34 | 2010 |
| Successful induction therapy with decitabine in refractory childhood acute lymphoblastic leukemia L Yanez, A Bermudez, C Richard, E Bureo, A Iriondo Leukemia 23 (7), 1342-1343, 2009 | 34 | 2009 |
| Ponatinib, chemotherapy, and transplant in adults with Philadelphia chromosome–positive acute lymphoblastic leukemia JM Ribera, O García-Calduch, J Ribera, P Montesinos, I Cano-Ferri, ... Blood advances 6 (18), 5395-5402, 2022 | 32 | 2022 |
| Interim results from the first phase 1 clinical study of the B-cell maturation antigen (BCMA) 2+ 1 T-cell engager (TCE) CC-93269 in patients (pts) with relapsed/refractory … LJ Costa, SW Wong, A Bermudez, J De la Rubia, MV Mateos, EM Ocio, ... EHA Library 295025, S205, 2020 | 31 | 2020 |
| Higher busulfan dose intensity appears to improve leukemia-free and overall survival in AML allografted in CR2: an analysis from the Acute Leukemia Working Party of the … MA Kharfan-Dabaja, M Labopin, A Bazarbachi, G Socie, N Kroeger, ... Leukemia research 39 (9), 933-937, 2015 | 28 | 2015 |
| Haplo-Cord transplantation compared to haploidentical transplantation with post-transplant cyclophosphamide in patients with AML M Kwon, G Bautista, P Balsalobre, I Sanchez-Ortega, P Montesinos, ... Bone Marrow Transplantation 52 (8), 1138-1143, 2017 | 27 | 2017 |
| A prospective controlled study of a computer-assisted acenocoumarol dosage program F Marco, C Sedano, A Bermúdez, M López-Duarte, ... Pathophysiology of haemostasis and thrombosis 33 (2), 59-63, 2003 | 26 | 2003 |
